1.Reversal effect on ADM resistance in human leukaemia cell subline resistant to ADM(K562/ADM) of anti-FasL
Tianrong ZHENG ; Dongmei ZHOU ; Zuofu XIE
China Oncology 2000;0(06):-
Purpose:To explore the effect of anti-FasL on ADM resistance of K562/ADM cell subline and its possible mechanism.Methods:Control group,untreated with VER or anti-FasL ,VER-treated group,anti-FasL-treated group and anti-FasL +VER-treated group were set up. MTT、FCM、TUNEL、S-P immunechemistry and RT-PCR assay were used for detection.Results:Anti-FasL or VER treatment was capable of strengthening sensitivity of K562/ADM cells to ADM,ID 50 of anti-FasL and VER was 200ng/ml and 6?g/ml,respectively;DNA content of apoptosis from cycling analysis curve of K562/ADM cell was 7.42%,32.10%,49.29%,56.26%,respectively,and positive rate in situ apoptosis was 4.5%,36%,45%,58%,respectively,which represented a tendency of gradual increase. Anti-FasL was capable of effecting FasL and bcl-2 expression,but not Pgp.Conclusions:Anti-FasL alone or synergically with VER was capable of reversing ADM resistance of K562/ADM cell,which may be used as a novel reversor of multidrug resistance.
2.Mechanism of proliferation migration and differentiation of neural stem cells
Dongmei JIA ; Yiwu ZHOU ; Guanglong HE
Chinese Journal of Forensic Medicine 1986;0(01):-
Recent researches have showed that neural stem cells be isolated not only in the embryonic nervous system but also in adult nervous system. Neural stem cells have some capacity for self-renewal, migration and can differentiate into neurons, astrocyte and oligodendrocyte. This provides a basis in therapy of degenerative diseases and functional recovery of the central nervous system injury. Also helps in the study of determining the postmortem interval ( PMI) and postmortem injury. Distribution, biological characteristic, identification and the factors effecting the proliferation, differentiation and migration with reference to therapy of neural stem cells and applications in forensic pathology are reviewed.
3.8 aged patients with coranary artery fistula
Dongmei SHI ; Yujie ZHOU ; Weijun ZHANG
Chinese Journal of Interventional Cardiology 1996;0(01):-
Objective To investigate the character and differentiation diagnosis of coronary artery fistula in aged.Methods Clinical symptom, sign and laboratory examination were analyzed in 8 aged patients with coronary artery fistula. Results Myocardial ischemia is the main manifestation of agedness coronary artery fistula, and should be discriminated with coronary artery disease. Conclusion If myocardial ischemia symptom aggravates with age in patient with long-term angina, coronary angiogram is the most dependable method.
4.Inhibition of phyticacid and bivarudin on platelets activation in vitro
Jinghan LIU ; Jun ZHOU ; Dongmei WANG
Chinese Journal of Blood Transfusion 1988;0(03):-
Objective To select the reversible activation inhibitors for platelet retreating before lyophilization.Methods Effects of phyticacid and bivarudin of different concentration on platelets in vitro viability and functional activity were evalued by the maximal aggregation of platelets,CD62p and PAC-1 expressions and re-expressions stimulated by thrombin,and platelets SPAT.Results Expression of CD62p and PAC-1 increased after treatment.Phyticacid with a concentration of 1mmol/L could decline the PAC-1 expression,but could not decline the re-expression of CD62p and PAC-1,and the aggregation reaction induced by propylgallate was also maintained.Bivarudin at a concentration of 1mmol/L could inhibit both expressions(0.78% and 0.24%) and re-expressions(7.00% and 14.39%) of CD62p and PAC-1.Aggregation reactions stimulated by inducers except thrombin were maintained.With phyticacid concentration ≤2mmol/L,the aggregation time was prolonged;while the aggregation time was the same with ≤ 3?mol/L bivarudin.Conclusions Phyticacid with the concentration of 1mmol/L could inhibit the GPIIb/IIIa conformation change of platelet,while 1?mol/L Bivarudin could inhibit platelet activation,and a better protection will be observed with a lower concentration.
5.Effect of losartan on urinary albumin excretion in experimental diabetic rats
Dongmei ZHANG ; Huiju ZHONG ; Min ZHOU
Chinese Journal of Diabetes 2000;8(6):360-361,359
Objective To observe the effect of losartan on urinary albumin excretion in streptozotocin diabetic rats.Methods The following groups of rats were studied:normal control rats(NC),diabetic control rats (DC),diabetic rats treated with losartan 〔20mg/(kg*d)〕(DL) and diabetic rats treated with perindopril (2mg/(kg*d)〕(DP).Urinary albumin was observed at the 4th、8th、12th and 16th week.Results Urinary albumin excretion of diabetic rats treated with losartan or perindopril were significantly lower than that of diabetic untreated group (P<0.01).The effect was not different between losartan treated and perindopril treated rats.Conclusion The results suggested that losartan can reduce urinary albumin excretion in diabetic rats.
6.Renal Protective Effect of Perindopril in Diabetic Rats
Huiju ZHONG ; Dongmei ZHANG ; Min ZHOU
Journal of Chinese Physician 2001;0(05):-
Objective To study the renal protective effect of perindopril in diabetic rats. Methods The following groups of rats were studied: normal control rats ,diabetic control rats and diabetic rats treated with perindopril (2mg?kg -1 ?d -1 ) . After 4 weeks or 12 weeks treatment , alterations of renal ultrastructure were observed in each group, Urinary albumin excretion was observed every 4 weeks.Results Urinary albumin excretion of diabetic rats treated with perindopril were significantly lower than that of diabetic untreated group(P
7.Myocardial protective effect of ulinastatin during open heart surgery with cardiopulmonary bypass
Dongmei MENG ; Jingui YU ; Guangli ZHOU
Chinese Journal of Anesthesiology 1994;0(06):-
Objective To investigate the protective effect of ulinastatin on myocardium against ischemia-reperfusion injury in open heart surgery with cardiopulmonary bypass (CPB) .Methods Twenty ASA Ⅰ - Ⅱ patients undergoing atrioseptopexy or surgical repair of VSD under CPB were randomly divided into two groups: in ulinastatin group (U n = 10) patients received ulinastatin 12000 unit?kg-1, half of the dose was given iv, 10 min before aorta cannulation and another half was added into the priming fluid; in control group (C n = 10) the patients received same volume of saline instead of ulinastatin. Premedication consisted of intramuscular pethidine 1 mg?kg-1 and scopolamine 0.01 mg?kg-1 .Anesthesia was induced with midazolam 0.1 mg?kg-1, fentanyl 10 ?g?kg-1 and pancuronium 0.1 mg**kg-1 and maintained with fentanyl, enflurane or isoflurane, diazepam and pancuronium. Arterial blood samples were taken before CPB (T1), at release of the aortic cross-clamp (T2), 30 min after aortic release (T3), 4h and 24h after discontinuation of CPB (T4, T5 ) for determination of plasma levels of cardiac troponin I (cTnI), creatine phosphokinase (CK) and creative phosphokinase isoenzyme (CK-MB) .Results The demographic data were comparable between the two groups. The CPB time, aortic cross-clamping time and duration of operation were also comparable. The plasma cTnI level and CK, CK-MB activity were all within normal range before CPB in both groups. In group C the plasma level of cTnI started increasing at T2, peaked at T4 and started decreasing at T5. In group U the plasma level of cTnI at T3 and T4 was significantly higher than the baseline (P
8.The clinic application of implantation iodine-125 seeds guided by CT for elderly non-small cell lung cancer
Yao ZHANG ; Dongmei ZHOU ; Xiaodong LUO
Chinese Journal of Primary Medicine and Pharmacy 2011;18(23):3216-3217
Objective To evaluate the efficacy and safety of brachytherapy by percutaneous paracentesis implantation of iodine-125 seeds for elderly non-small cell lung cancer.Methods 18 patients with peripheral lung cancer were undergone brachytherapy by percutaneous paracentesis implantation of iodine-125 seeds.The effect was evaluated by periodically chest CT.The complications were analyzed.Results 18 patients were observed one,two and six months after operation.CR,PR,SD were seen in 27.8%(3/18),66.7%(14/18),5.6%(1/18)respectively of the patients.Pneumothorax,hemoptysis were seen in 16.67%(3/18),95.37%(17/18),no pleural cavity bleeding.Conclusion Brachytherapy by percutaneous paracentesis implantation of iodine-125 seeds for lung cancer was effecitve.The complications were easy to treat.The methods of implantation of iodine-125 seeds could fully play the advantages of CT,and reduce the damage to the body when raising the tumorous control rate.
9.The effects of blocking renin-angiotensin system with losartan or perindopril on renal angiotensin Ⅱ and its type 1 receptor expression in STZ-induced diabetic rats
Dongmei ZHANG ; Huiju ZHONG ; Min ZHOU
Chinese Journal of Diabetes 2005;13(2):131-133
Objective To observe the effects of blocking renin-angiotensin system with losartan or perindopril on renal angiotensinⅡand its type 1 receptor (AT1R) expression in STZ-induced (diabetic) rats. Methods Male SD rats were randomly divided into 2 groups: normal control group (NC) and (diabetic) group. Diabetes was induced by STZ (65 mg/kg) abdominal injection. Four weeks later, diabetic rats were further divided into 4 groups: diabetic rats treated with losartan (DL, 20 mg·kg-1·d-1),diabetic rats treated with perindopril (DP,2 mg·kg-1·d-1) and diabetic untreated control group(DC). Radioimmunoassay was used to measure plasma and renal angiotensin (Ⅱ.)Expression of AT1R was detected by RT-PCR in each group before and after 12 week′s treatment. Results At the 4th week, renal AT1R expression decreased. At the 16th week, plasma angiotensinⅡ,renal angiotensinⅡand AT1R mRNA in diabetic untreated group were significantly higher than those in normal rats. (Renal) angiotensinⅡand AT1R in losartan or perindopril-treatmented group were significantly lower than those in DC group. Conclusion Intrarenal RAS is abnormal in STZ-induced diabetic rats. Renoprotective effects of losartan and perindopril may partly induced by inhibiting renal angiotensinⅡ and AT1R (expression.)
10.Interpretation of ISO 15189:2012“Medical laboratories-Requirements for quality and competence” -Requirements for IVD manufacturers
Dongmei HU ; Yali ZHOU ; Peijun ZHAI
Chinese Journal of Laboratory Medicine 2015;(7):502-504
In vitro diagnostic ( IVD) manufacturers were important suppliers of external servicesto medical laboratories .There equipment , reagents , calibration and maintenauce services played an important role in ensuring the quality of medical laboratory tests .It is also helpful for IVD manufacturers to establish and maintain a good reputation and credibility .ISO 15189:2012“Medical laboratories -Requirements for quality and competence” was issued onNovember 1, 2012, which replaced the second edition (ISO 15189:2007).Requirements related to IVD manufacturers are involved in the new edition standard .The article aimed to help medical laboratories and IVD manufacturers understand the requirements ; therefore , laboratories would know how to select suppliers based on their ability to supply external services , IVD manufacturers would know how to meet the needs of laboratories , and the cooperation between IVD manufacturers and laboratories would be facilitated .